Back to News
Market Impact: 0.25

Noteworthy Tuesday Option Activity: CRWD, LLY, DECK

LLYDECKCRWDNDAQ
Futures & OptionsCompany FundamentalsDerivatives & VolatilityMarket Technicals & FlowsHealthcare & Biotech
Noteworthy Tuesday Option Activity: CRWD, LLY, DECK

Eli Lilly (LLY) and Deckers Outdoor Corp. (DECK) are experiencing significantly higher than average options trading volume today. LLY's options volume reached 132.1% of its average daily trading volume, with notable activity in the $850 strike call option expiring July 2025. Similarly, DECK's options volume hit 68.7% of its average, driven by the $105 strike call option expiring June 2025, indicating increased investor interest in these specific strike prices and expiration dates.

Analysis

Eli Lilly (LLY) has demonstrated a significant surge in options trading activity, with today's volume reaching 67,276 contracts, equivalent to approximately 6.7 million underlying shares. This figure represents a substantial 132.1% of LLY's average daily trading volume of 5.1 million shares over the past month. Notably, high volume was concentrated in the $850 strike call option expiring July 18, 2025, which accounted for 21,085 contracts, or about 2.1 million underlying LLY shares. Concurrently, Deckers Outdoor Corp. (DECK) also experienced elevated options volume, with 25,724 contracts traded, representing approximately 2.6 million underlying shares. This activity constitutes 68.7% of DECK's average daily trading volume of 3.7 million shares. For Deckers, specific interest was directed towards the $105 strike call option expiring June 06, 2025, with 2,169 contracts traded, translating to roughly 216,900 underlying shares. The pronounced options activity in these specific long-dated call contracts for both LLY and DECK suggests heightened investor interest, potentially indicating speculative bets on future price appreciation or significant institutional hedging or positioning strategies.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo